Table of Contents
ISRN Pathology
Volume 2012, Article ID 232171, 6 pages
http://dx.doi.org/10.5402/2012/232171
Research Article

Ki-67 Labeling Index in Primary Invasive Breast Cancer from Sudanese Patients: A Pilot Study

1Department of Molecular Biology, National Cancer Institute (NCI-UG), University of Gezira, P.O. Box 20, Hospital Street, Wad Medani, Sudan
2Department of Medicine, Dentistry and Biotechnology, “G. d’Annunzio” University and Unit of General Pathology, Aging Research Center (CeSI), “G. d'Annunzio” University Foundation, via Colle dell’Ara, 66013 Chieti, Italy
3Department of Histopathology & Cytopathology, Radiation & Isotope Centre Khartoum (RICK), Algaser Street, P.O. Box 846, Khartoum, Sudan
4Division of Pathology, European School of Oncology (IEO), via Ripamonti 435, 20141 Milan, Italy

Received 6 November 2012; Accepted 22 November 2012

Academic Editors: L. Colomo, K. Nakanishi, and M. A. Sughayer

Copyright © 2012 Khalid Dafaallah Awadelkarim et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. M. Perou, T. Sørile, M. B. Eisen et al., “Molecular portraits of human breast tumours,” Nature, vol. 406, no. 6797, pp. 747–752, 2000. View at Publisher · View at Google Scholar · View at Scopus
  2. T. Sorliea, C. M. Perou, R. Tibshirani et al., “Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications,” Proceedings of the National Academy of Sciences of the United States of America, vol. 98, no. 19, pp. 10869–10874, 2001. View at Publisher · View at Google Scholar
  3. F. A. Tavassoli and P. Devilee, Eds., World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of the Breast and Female Genital Organs, IARC Press, Lyon, France, 2003.
  4. J. F. Simpson, R. Gray, L. G. Dressier et al., “Prognostic value of histologic grade and proliferative activity in axillary node-positive breast cancer: results from the Eastern Cooperative Oncology Group companion study, EST 4189,” Journal of Clinical Oncology, vol. 18, no. 10, pp. 2059–2069, 2000. View at Google Scholar · View at Scopus
  5. F. L. Greene, D. L. Page, I. D. Fleming et al., Eds., AJCC Cancer Staging Manual, Springer, New York, NY, USA, 6th edition, 2002.
  6. W. F. Anderson, B. E. Chen, I. Jatoi, and P. S. Rosenberg, “Effects of estrogen receptor expression and histopathology on annual hazard rates of death from breast cancer,” Breast Cancer Research and Treatment, vol. 100, no. 1, pp. 121–126, 2006. View at Publisher · View at Google Scholar · View at Scopus
  7. V. J. Bardou, G. Arpino, R. M. Elledge, C. K. Osborne, and G. M. Clark, “Progesterone receptor status significantly improves outcome prediction over estrogen receptor status alone for adjuvant endocrine therapy in two large breast cancer databases,” Journal of Clinical Oncology, vol. 21, no. 10, pp. 1973–1979, 2003. View at Publisher · View at Google Scholar · View at Scopus
  8. G. Arpino, S. J. Green, D. C. Allred et al., “HER-2 amplification, HER-1 expression, and tamoxifen response in estrogen receptor-positive metastatic breast cancer: a southwest oncology group study,” Clinical Cancer Research, vol. 10, no. 17, pp. 5670–5676, 2004. View at Publisher · View at Google Scholar · View at Scopus
  9. K. D. Awadelkarim, A. A. Mohamedani, and M. Barberis, “Role of pathology in sub-Saharan Africa: an example from Sudan,” Pathology and Laboratory Medicine International, vol. 2, pp. 49–57, 2010. View at Google Scholar
  10. K. D. Awadelkarim, C. Arizzi, E. O. M. Elamin et al., “Pathological, clinical and prognostic characteristics of breast cancer in Central Sudan versus Northern Italy: implications for breast cancer in Africa,” Histopathology, vol. 52, no. 4, pp. 445–456, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. K. D. Awadelkarim, C. Arizzi, E. O. Musa et al., “Basal-like phenotype in a breast carcinoma case series from Sudan: prevalence and clinical/pathological correlations,” Pathology Research International, vol. 2011, Article ID 806831, 10 pages, 2011. View at Publisher · View at Google Scholar
  12. A. Urruticoechea, I. E. Smith, and M. Dowsett, “Proliferation marker Ki-67 in early breast cancer,” Journal of Clinical Oncology, vol. 23, no. 28, pp. 7212–7220, 2005. View at Publisher · View at Google Scholar · View at Scopus
  13. D. McCormick, H. Chong, C. Hobbs, C. Datta, and P. A. Hall, “Detection of the Ki-67 antigen in fixed and wax-embedded sections with the monoclonal antibody MIB1,” Histopathology, vol. 41, no. 3, pp. 173–178, 2002. View at Publisher · View at Google Scholar
  14. E. De Azambuja, F. Cardoso, G. De Castro et al., “Ki-67 as prognostic marker in early breast cancer: a meta-analysis of published studies involving 12 155 patients,” British Journal of Cancer, vol. 96, no. 10, pp. 1504–1513, 2007. View at Publisher · View at Google Scholar · View at Scopus
  15. G. Viale, M. M. Regan, E. Maiorano et al., “Prognostic and predictive value of centrally reviewed expression of estrogen and progesterone receptors in a randomized trial comparing letrozole and tamoxifen adjuvant therapy for postmenopausal early breast cancer: BIG 1-98,” Journal of Clinical Oncology, vol. 25, no. 25, pp. 3846–3852, 2007. View at Publisher · View at Google Scholar · View at Scopus
  16. G. Viale, A. Giobbie-Hurder, M. M. Regan et al., “Prognostic and predictive value of centrally reviewed Ki-67 labeling index in postmenopausal women with endocrine-responsive breast cancer: results from breast international group trial 1-98 comparing adjuvant tamoxifen with letrozole,” Journal of Clinical Oncology, vol. 26, no. 34, pp. 5569–5575, 2008. View at Publisher · View at Google Scholar · View at Scopus
  17. E. Luporsi, F. André, F. Spyratos et al., “Ki-67: level of evidence and methodological considerations for its role in the clinical management of breast cancer: analytical and critical review,” Breast Cancer Research and Treatment, vol. 132, no. 3, pp. 895–915, 2012. View at Publisher · View at Google Scholar
  18. A. Gondos, H. Brenner, H. Wabinga, and D. M. Parkin, “Cancer survival in Kampala, Uganda,” British Journal of Cancer, vol. 92, no. 9, pp. 1808–1812, 2005. View at Publisher · View at Google Scholar · View at Scopus
  19. A. Gondos, E. Chokunonga, H. Brenner et al., “Cancer survival in a southern african urban population,” International Journal of Cancer, vol. 112, no. 5, pp. 860–864, 2004. View at Publisher · View at Google Scholar · View at Scopus
  20. R. Sankaranarayanan, R. Swaminathan, H. Brenner et al., “Cancer survival in Africa, Asia, and Central America: a population-based study,” The Lancet Oncology, vol. 11, no. 2, pp. 165–173.
  21. H. M. A. Hamad, “Cancer initiatives in Sudan,” Annals of Oncology, vol. 17, supplement 8, pp. viii32–viii36, 2006. View at Publisher · View at Google Scholar · View at Scopus
  22. H. G. Ahmed, A. S. Ali, and A. O. Almobarak, “Frequency of breast cancer among sudanese patients with breast palpable lumps,” Indian Journal of Cancer, vol. 47, no. 1, pp. 23–26, 2010. View at Publisher · View at Google Scholar · View at Scopus
  23. A. E. Pinto, S. André, T. Pereira, S. Nóbrega, and J. Soares, “Prognostic comparative study of S-phase fraction and Ki-67 index in breast carcinoma,” Journal of Clinical Pathology, vol. 54, no. 7, pp. 543–549, 2001. View at Publisher · View at Google Scholar · View at Scopus
  24. M. P. Mbonde, H. Amir, L. A. Akslen, and J. N. Kitinya, “Expression of oestrogen and progesterone receptors, Ki-67, p53 and BCL-2 proteins, cathepsin D, urokinase plasminogen activator and urokinase plasminogen activator-receptors in carcinomas of the female breast in an African population,” East African Medical Journal, vol. 78, no. 7, pp. 360–365, 2001. View at Google Scholar · View at Scopus
  25. H. Nalwoga, J. B. Arnes, H. Wabinga, and L. A. Akslen, “Frequency of the basal-like phenotype in African breast cancer,” Acta pathologica, Microbiologica, et Immunologica Scandinavica, vol. 115, no. 12, pp. 1391–1399, 2007. View at Publisher · View at Google Scholar · View at Scopus
  26. K. D. Awadelkarim, C. Arizzi, E. O. Musa et al., “Basal-like phenotype in a breast carcinoma case series from Sudan: prevalence and clinical/pathological correlations,” Pathology Research International, vol. 2011, Article ID 806831, 10 pages, 2011. View at Publisher · View at Google Scholar
  27. P. Royston, D. G. Altman, and W. Sauerbrei, “Dichotomizing continuous predictors in multiple regression: a bad idea,” Statistics in Medicine, vol. 25, no. 1, pp. 127–141, 2006. View at Publisher · View at Google Scholar · View at Scopus